Dedicare AB (SE:DEDI)
:DEDI
Top Page
Dedicare AB
(DEDI)
Select Model
Select Model
Rating:56Neutral
Price Target:
kr43.00
▲(0.82% Upside)
Action:DowngradedDate:02/08/26
The score is held back primarily by weakening financial performance (revenue declines and steep margin compression in 2024–2025) and bearish technicals (price below key moving averages with negative MACD). Offsetting factors include a solid balance sheet/cash conversion and relatively attractive valuation with a high dividend yield.
Positive Factors
Balance Sheet Strength
Manageable leverage with debt-to-equity ~0.29 and a stable equity base supports financial resilience. This gives Dedicare flexibility to fund working capital and payroll in a labour-intensive staffing model, and cushions the business during cyclical demand downturns.
Negative Factors
Revenue Weakness
Two consecutive years of declining revenue reduce scale and bargaining leverage with clients and candidates. Lower volumes pressure fixed operating costs and recruiting investment, making it harder to restore margins and reinvest in growth initiatives without structural demand improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Manageable leverage with debt-to-equity ~0.29 and a stable equity base supports financial resilience. This gives Dedicare flexibility to fund working capital and payroll in a labour-intensive staffing model, and cushions the business during cyclical demand downturns.
Read all positive factors
Dedicare AB (DEDI) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr380.59M
Dividend Yield5.95%
Average Volume (3M)20.96K
Price to Earnings (P/E)12.3
Beta (1Y)-0.05
Revenue Growth-17.43%
EPS Growth-39.61%
CountrySE
Employees904
SectorHealthcare
Sector Strength45
IndustryStaffing & Employment Services
Share Statistics
EPS (TTM)0.78
Shares Outstanding7,550,735
10 Day Avg. Volume24,037
30 Day Avg. Volume20,963
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)1.40
Price to Sales (P/S)0.28
P/FCF Ratio6.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.99
Revenue Forecast (FY)kr2.24B
Dedicare AB Business Overview & Revenue Model
Company Description
Dedicare AB (publ) operates as a staffing company in the healthcare industry primarily in Sweden, Norway, Finland, and Denmark. The company hires and recruits doctors, nurses, social workers, and managers, as well as other staff in health and soci...
How the Company Makes Money
Dedicare AB generates revenue through its staffing services, which include temporary and permanent placement of healthcare professionals. The company charges its clients a fee based on the hourly rates of the personnel provided, along with additio...
Dedicare AB Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
72
Positive
Cash Flow
67
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.45B | 1.72B | 1.97B | 1.77B | 1.25B |
| Gross Profit | 30.80M | 444.92M | 351.50M | 529.42M | 337.40M |
| EBITDA | 64.10M | 89.34M | 171.42M | 154.37M | 102.31M |
| Net Income | 33.10M | 47.07M | 110.40M | 101.30M | 65.56M |
Balance Sheet | |||||
| Total Assets | 596.20M | 628.76M | 727.32M | 742.68M | 497.86M |
| Cash, Cash Equivalents and Short-Term Investments | 116.00M | 138.58M | 187.15M | 142.80M | 132.43M |
| Total Debt | 85.70M | 38.05M | 87.96M | 116.01M | 33.55M |
| Total Liabilities | 305.10M | 329.46M | 417.39M | 480.13M | 319.37M |
| Stockholders Equity | 291.10M | 299.30M | 309.93M | 262.56M | 178.49M |
Cash Flow | |||||
| Free Cash Flow | 64.20M | 78.03M | 140.85M | 99.97M | 67.30M |
| Operating Cash Flow | 64.40M | 81.28M | 145.40M | 105.34M | 69.59M |
| Investing Cash Flow | -27.00M | -39.47M | -9.67M | -68.61M | -2.29M |
| Financing Cash Flow | -48.80M | -88.19M | -81.83M | -30.07M | -36.74M |
Dedicare AB Technical Analysis
Negative
42.65
Price Trends
40.68
Negative
42.02
Negative
43.89
Negative
Market Momentum
-0.21
Negative
44.78
Neutral
62.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:DEDI, the sentiment is Negative. The current price of 42.65 is above the 20-day moving average (MA) of 39.91, above the 50-day MA of 40.68, and below the 200-day MA of 43.89, indicating a bearish trend. The MACD of -0.21 indicates Negative momentum. The RSI at 44.78 is Neutral, neither overbought nor oversold. The STOCH value of 62.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:DEDI.
Dedicare AB Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
56 Neutral | kr380.59M | 12.28 | ― | 5.95% | -17.43% | -39.61% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | kr126.01M | -6.17 | -25.98% | ― | -20.88% | 14.14% | |
46 Neutral | kr21.70M | -1.44 | -8.58% | ― | -11.42% | -116.51% | |
40 Underperform | kr233.65M | -831.83 | -0.23% | ― | -17.32% | 36.05% |
* Healthcare Sector Average
SE:DEDI
Dedicare AB
39.80
-5.55
-12.24%
SE:WISE
Wise Group AB
17.05
-1.35
-7.34%
SE:PION.B
Poolia AB Class B
4.85
-0.27
-5.27%
SE:HEGR
Hedera Group AB
0.64
-2.13
-77.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.